Literature DB >> 290353

Effect of oral D-penicillamine treatment on experimental arthritis and associated immune responses in rabbits. III: Reduction of the monoarticular arthritis.

I M Hunneyball, G A Stewart, D R Stanworth.   

Abstract

Treatment of rabbits with D-penicillamine at doses up to 30 mg/kg, beginning either before or after the onset of antigen-induced experimental arthritis, diminished the severity of the inflammatory synovitis in a considerable proportion of animals as judged by both external joint measurements and terminal histopathological assessment. D-penicillamine treatment had no effect on serum haptoglobin concentration, haemoglobin concentration, or platelet count. The venous blood white cell count was raised when D-penicillamine treatment was started before immunisation but not when treatment began after the onset of arthritis. A transient loss of appetite was observed in animals starting D-penicillamine treatment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 290353      PMCID: PMC1000450          DOI: 10.1136/ard.38.3.271

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  The production of arthritis in rabbits by an immunological reaction to fibrin.

Authors:  D C DUMONDE; L E GLYNN
Journal:  Br J Exp Pathol       Date:  1962-08

2.  Effect of D(-)penicillamine on chronic experimental arthritis in rabbits.

Authors:  I M Hunneyball; G A Stewart; D R Stanworth
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

3.  The effect of drugs in established rabbit monoarticular arthritis.

Authors:  A Blackham; H Radziwonik
Journal:  Agents Actions       Date:  1977-10

4.  Production of a chronic arthritis with ovalbumin. Its retention in the rabbit knee joint.

Authors:  R Consden; A Doble; L E Glynn; A P Nind
Journal:  Ann Rheum Dis       Date:  1971-05       Impact factor: 19.103

5.  Experimental immune synovitis in the rabbit. Relative roles of cell mediated and humoral immunity.

Authors:  V M Goldberg; E M Lance; P Davis
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

6.  [The effect of D-penicillamine on experimental allergic arthritis in rabbits].

Authors:  W Püschel; M Rosenkranz; G Geiler; B Caffier; P Stiehl; V Richter
Journal:  Z Rheumatol       Date:  1976 May-Jun       Impact factor: 1.372

7.  The effects of oral D-penicillamine treatment on experimental arthritis and the associated immune response in rabbits. II. The effects on cellular parameters.

Authors:  I M Hunneyball; G A Stewart; D R Stanworth
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

8.  Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.

Authors:  E C Huskisson; T J Gibson; H W Balme; H Berry; H C Burry; R Grahame; F D Hart; D R Henderson; J A Wojtulewski
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

9.  ESTIMATION OF SERUM HAEMOGLOBIN-BINDING CAPACITY (HAPTOGLOBIN) ON SEPHADEX G.100.

Authors:  A P RATCLIFF; J HARDWICKE
Journal:  J Clin Pathol       Date:  1964-11       Impact factor: 3.411

10.  The effects of oral D-penicillamine treatment on experimental arthritis and the associated immune response in rabbits.

Authors:  I M Hunneyball; G A Stewart; D R Stanworth
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

View more
  3 in total

1.  Pharmacological studies of antigen-induced arthritis in BALB/c mice. II. The effects of second-line antirheumatic drugs and cytotoxic agents on the histopathological changes.

Authors:  I M Hunneyball; M J Crossley; M Spowage
Journal:  Agents Actions       Date:  1986-06

2.  Chronic immune synovitis in rabbits. II. Modulation by anti-inflammatory and anti-rheumatic agents.

Authors:  M B Goldlust; L C Rich
Journal:  Agents Actions       Date:  1981-12

3.  Some further effects of prednisolone and triamcinolone hexacetonide on experimental arthritis in rabbits.

Authors:  I M Hunneyball
Journal:  Agents Actions       Date:  1981-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.